European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.89% to 1,323.86 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Grifols (GRFS) and petroleum refiner Equinor (EQNR), which rose 6% and 3.9% respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria (BBVA) and biotech firm BioNTech (BNTX), which were up 2.7% and 1.7% respectively.

The decliners from continental Europe were led by biopharmaceutical companies Genfit (GNFT) and Cellectis (CLLS), which fell 9.7% and 4% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and medical device maker EDAP TMS (EDAP), which dropped 2.9% and 2.1% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX) and insurance provider Prudential (PUK), which increased 7.1% and 2.5% respectively. They were followed by communications company WPP (WPP) and cruise line operator Carnival (CUK), which rose 1.6% and 1.4% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and biotech firm Trinity Biotech (TRIB), which tumbled 13% and 10% respectively. They were followed by software firm Endava (DAVA) and biopharmaceutical company Amarin (AMRN), which lost 4.4% and 3.9% respectively.